M. Boisdron‐Celle
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
- Neutropenia and Cancer Infections
- Pharmacology top 2%
Papers in
- Oncology 52
- Colorectal Cancer Treatments and Studies 33
- Cancer Treatment and Pharmacology 24
- Neutropenia and Cancer Infections 10
- Pancreatic and Hepatic Oncology Research 7
- Co-authors
- Érick GamelinAlain MorelLaurence GamelinR. DelvaPhilippe MeneïJean‐Pierre BenoîtS TraoréVéronique Guerin‐Meyer
- Journals
- Journal of Clinical Oncology (9 papers)Clinical Cancer Research (3 papers)European Journal of Cancer (3 papers)Cancers (2 papers)Cancer Letters (2 papers)
- Partner nations
- FranceUnited StatesPoland
In The Last Decade
M. Boisdron‐Celle
65 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 117
- Oncology 2.1k
- Pharmacology 251
- Pharmaceutical Science 154
- Dermatology 190
- Genetics 205
Countries citing papers authored by M. Boisdron‐Celle
This map shows the geographic impact of M. Boisdron‐Celle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Boisdron‐Celle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Boisdron‐Celle more than expected).
Fields of papers citing papers by M. Boisdron‐Celle
This network shows the impact of papers produced by M. Boisdron‐Celle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Boisdron‐Celle. The network helps show where M. Boisdron‐Celle may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Boisdron‐Celle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2021 | 6 | |
| 3 | 2014 | 17 | |
| 4 | 2012 | 67 | |
| 5 | 2011 | 47 | |
| 6 | 2011 | 12 | |
| 7 | 2010 | 4 | |
| 8 | 2010 | 4 | |
| 9 | 2008 | 113 | |
| 10 | 2008 | 7 | |
| 11 | 2007 | 6 | |
| 12 | Neurotoxicité de l’oxaliplatine | 2006 | 1 |
| 13 | 2006 | 173 | |
| 14 | 2006 | 39 | |
| 15 | 2006 | 3 | |
| 16 | 2005 | 48 | |
| 17 | 2005 | 26 | |
| 18 | 2002 | 18 | |
| 19 | Pharmacocinétique clinique comparative des dérivés du platine | 2001 | 1 |
| 20 | 1999 | 75 |
About M. Boisdron‐Celle
M. Boisdron‐Celle is a scholar working on Oncology, Hepatology, Pharmaceutical Science, Genetics and Pathology and Forensic Medicine, having authored 65 papers that have together received 3.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (33 papers), Cancer Treatment and Pharmacology (24 papers), Neutropenia and Cancer Infections (10 papers), Cancer therapeutics and mechanisms (9 papers), Biochemical and Molecular Research (8 papers), Pancreatic and Hepatic Oncology Research (7 papers), Genetic factors in colorectal cancer (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). The work is most often cited by research in Oncology (2.1k citations), Pharmacology (251 citations), Pharmaceutical Science (154 citations), Dermatology (190 citations) and Genetics (205 citations). M. Boisdron‐Celle has collaborated with scholars based in France, United States and Poland. Frequent co-authors include Érick Gamelin, Alain Morel, Laurence Gamelin, R. Delva, Philippe Meneï, Jean‐Pierre Benoît, S Traoré, Véronique Guerin‐Meyer, Norbert Ifrah and F Larra. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, European Journal of Cancer, Cancers and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.